Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Open in API
Filings indexed 529 across all filing types
Latest filing 2021-06-21 Call Transcript
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 70% confidence The document contains a schedule or list of conference calls and virtual meetings with investors and securities firms, including dates and meeting types. There is no financial data, report content, or regulatory filing information. The content resembles a summary or agenda of investor-related calls and conferences, which aligns with a Call Transcript (CT) or Investor Presentation (IP) category. However, since it is only a schedule without transcript or presentation content, it is closest to a Call Transcript category as it relates to conference calls and meetings. Given the lack of actual transcript text, the best fit is Call Transcript (CT) as it relates to conference calls and investor meetings.
2021-06-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges referencing Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the availability of the transcript of a conference call held on June 2, 2021, and provides a link to the transcript on the company's website. The document itself does not contain the transcript but announces its availability. The document length is short (1337 characters), and it is an announcement rather than the full transcript. According to the rules, announcements about availability of transcripts should be classified as Regulatory Filings (RNS) because it is a general regulatory announcement and not the full call transcript itself.
2021-06-14 English
Related Party Transactions
Regulatory Filings
2021-06-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation letter to the stock exchange about a conference call scheduled for June 2, 2021, to discuss the acquisition of Unitop Chemicals. It includes dial-in details, timing, and a brief company description. The document is a notification of an upcoming conference call rather than the transcript or detailed content of the call itself. It is not a financial report, earnings release, or management discussion document. The primary purpose is to inform investors and analysts about the call, which fits the definition of a Call Transcript (CT) only if it contained the full transcript. Since this is only an announcement/intimation of the call, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement under SEBI regulations and does not fit other categories. The document length (6503 characters) is moderate but contains no financial data or transcript content. Therefore, the best classification is Regulatory Filings (RNS).
2021-06-02 English
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release dated June 2, 2021, announcing Rossari Biotech Limited's acquisition of Unitop Chemicals. It details the transaction terms, strategic rationale, financial considerations, and includes statements from company executives. The document is not a full financial report, audit, or regulatory filing but a corporate announcement about a capital transaction. It does not contain financial statements or detailed financial analysis but focuses on the acquisition update. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (8845 characters) and content confirm it is a substantive announcement rather than a brief notice or report publication announcement.
2021-06-02 English
Acquisition
M&A Activity Classification · 95% confidence The document is an official communication from Rossari Biotech Limited to stock exchanges (BSE and NSE) regarding an acquisition agreement to acquire 100% equity share capital of Unitop Chemicals Private Limited. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30, which pertains to disclosure of material events. The content includes detailed disclosure about the acquisition, including the nature of the transaction, consideration, timeline, and regulatory approvals. There is no financial statement or report data, but rather an announcement of a corporate transaction. This fits the category of M&A Activity announcements under Regulation 30 disclosures. The document is not a full merger proxy or tender offer filing (MA), but an announcement of acquisition activity (TAR). The length and detail confirm it is not a brief report publication announcement or a regulatory filing fallback. Therefore, the classification is M&A Activity (TAR).
2021-06-02 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.